Communiqués Avedro, Inc.

Actions

AVDR

US05355N1090

Temps Différé Nasdaq Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		+0,61 %	-.--%

2019	Avedro, Inc. annonce des résultats non audités pour le deuxième trimestre et le semestre clos le 30 juin 2019 ; révise les prévisions de chiffre d'affaires pour l'ensemble de l'exercice 2019.	CI
2019	Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm	09/09/20	BU
INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm	08/09/20	BU
AVEDRO INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	21/11/19	AQ
AVEDRO INC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	18/11/19	AQ
Avedro, Inc. Announces Third Quarter 2019 Financial Results	06/11/19	GL
Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting	09/10/19	GL
Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS	11/09/19	GL
AVEDRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avedro, Inc. - AVDR	13/08/19	BU
Avedro, Inc. Announces Second Quarter 2019 Financial Results	07/08/19	GL
Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019	25/07/19	GL
Avedro, Inc. Announces First Quarter 2019 Financial Results	09/05/19	GL
Avedro, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference	30/04/19	GL
Avedro to Present Research on Proprietary Corneal Cross-Linking Technologies at 2019 ARVO Annual Meeting	22/04/19	GL
UPDATE -- Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus	05/04/19	GL
Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus	05/04/19	GL
Avedro, Inc. Announces Appointment of Patrick B. Jacques as Vice President of Sales	13/03/19	GL
Avedro, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on March 21, 2019	28/02/19	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Nos Contenus Gratuits vous Aident à Sécuriser et Augmenter la Performance de vos Investissements

Sécuriser mes Investissements

fermer